Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

52.02

+3.07 (6.27%)

At close: May 16, 2025, 4:00 PM

51.86

-0.16 (-0.31%)

After-hours: May 16, 2025, 6:15 PM EDT

Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of $6.41 billion as of May 16, 2025. Its market cap has increased by 32.66% in one year.

Market Cap

6.41B

Enterprise Value

7.20B

1-Year Change

32.66%

Ranking

#1121

Market Cap Chart

Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $6.41B, an increase of 79,035.26%. That is a compound annual growth rate of 37.04%.

Market Cap History

Date	Market Cap	% Change
May 15, 2025	6.03B	-0.84%
Dec 31, 2024	6.08B	24.59%
Dec 29, 2023	4.88B	-36.54%
Dec 30, 2022	7.69B	35.91%
Dec 31, 2021	5.66B	-1.95%
Dec 31, 2020	5.77B	122.23%
Dec 31, 2019	2.60B	22.85%
Dec 31, 2018	2.11B	-26.67%
Dec 29, 2017	2.88B	125.43%
Dec 30, 2016	1.28B	-42.33%
Dec 31, 2015	2.22B	83.35%
Dec 31, 2014	1.21B	-29.21%
Dec 31, 2013	1.71B	126.01%
Dec 31, 2012	756.30M	-23.30%
Dec 30, 2011	986.10M	23.98%
Dec 31, 2010	795.40M	47.84%
Dec 31, 2009	538.00M	17.96%
Dec 31, 2008	456.10M	-17.36%
Dec 31, 2007	551.90M	6.38%
Dec 29, 2006	518.80M	469.48%
Dec 30, 2005	91.10M	-13.07%
Dec 31, 2004	104.80M	1,193.83%

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly and Company	667.04B
Johnson & Johnson	355.34B
AbbVie	325.42B
Novo Nordisk	291.59B
UnitedHealth Group	290.59B
Abbott Laboratories	224.25B
Novartis AG	209.81B
AstraZeneca	209.59B

Market Cap Rankings